A detailed history of United Capital Financial Advisers, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 159,027 shares of MRK stock, worth $15.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
159,027
Previous 167,924 5.3%
Holding current value
$15.3 Million
Previous $20.8 Million 13.13%
% of portfolio
0.09%
Previous 0.18%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $988,901 - $1.15 Million
-8,897 Reduced 5.3%
159,027 $18.1 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $4.8 Million - $5.15 Million
-38,756 Reduced 18.75%
167,924 $20.8 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $3.84 Million - $4.48 Million
-33,939 Reduced 14.1%
206,680 $27.3 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $27.8 Million - $30.2 Million
-277,085 Reduced 53.52%
240,619 $26.2 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $1.69 Million - $1.87 Million
16,368 Added 3.26%
517,704 $53.3 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $865,513 - $943,370
-7,969 Reduced 1.56%
501,336 $57.8 Million
Q1 2023

Aug 14, 2023

BUY
$102.94 - $114.86 $592,934 - $661,593
5,760 Added 1.15%
507,096 $53.9 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $2.35 Million - $2.62 Million
-22,792 Reduced 4.28%
509,305 $54.2 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $121,104 - $155,272
1,385 Added 0.26%
532,097 $59 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $801,513 - $900,410
-9,482 Reduced 1.76%
530,712 $45.7 Million
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $16.4 Million - $18.6 Million
196,993 Added 57.4%
540,194 $49.2 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $57,631 - $64,601
784 Added 0.23%
343,201 $28.2 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $1.11 Million - $1.39 Million
-15,355 Reduced 4.29%
342,417 $26.2 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $503,121 - $553,307
-7,019 Reduced 1.92%
357,772 $26.9 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $673,710 - $745,192
9,582 Added 2.7%
364,791 $28.4 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $1.29 Million - $1.52 Million
18,687 Added 5.55%
355,209 $27.4 Million
Q4 2020

Feb 17, 2021

BUY
$71.77 - $79.65 $720,714 - $799,845
10,042 Added 3.08%
336,522 $27.5 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $724,921 - $821,702
9,906 Added 3.13%
326,480 $27.1 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $918,347 - $1.04 Million
13,041 Added 4.3%
316,574 $24.5 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $3.42 Million - $4.74 Million
-53,940 Reduced 15.09%
303,533 $21 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $1.52 Million - $1.72 Million
19,648 Added 5.82%
357,473 $32.5 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $20.3 Million - $22.1 Million
-266,526 Reduced 44.1%
337,825 $28.4 Million
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $1.48 Million - $1.72 Million
21,134 Added 3.62%
604,351 $50.7 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $55,316 - $63,091
-795 Reduced 0.14%
583,217 $48.5 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $1.76 Million - $2.04 Million
26,975 Added 4.84%
584,012 $44.6 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $9.21 Million - $10.8 Million
-159,628 Reduced 22.27%
557,037 $39.5 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $84,936 - $99,792
-1,671 Reduced 0.23%
716,665 $43.5 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $36.6 Million - $42.5 Million
718,336 New
718,336 $39.1 Million
Q4 2017

Feb 13, 2018

SELL
$51.62 - $61.64 $35.1 Million - $42 Million
-680,637 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $193,787 - $208,518
3,303 Added 0.49%
680,637 $43.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
677,334
677,334 $43.4 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.